Скачать с ютуб CRT 25: AGENT IDE: 2Y Outcomes в хорошем качестве

CRT 25: AGENT IDE: 2Y Outcomes

CRT 25 - Two-year safety and effectiveness outcomes of the Agent drug coated balloon (DCB) for the treatment of in-stent restenosis show a major reduction in target lesion failure, including cardiac death, myocardial infarction and target lesion revascularization, compared to balloon angioplasty. The Agent DCB also caused a significant reduction in all target lesion events in comparison with the control arm. Dr Jeffrey Moses (Columbia University Medical Center, New York, US) sits down to outline the two-year outcomes from AGENT IDE (NCT04647253; Boston Scientific Corporation), a prospective, 2:1 randomized, multi-centre trail. AGENT IDE aimed to assess the safety and effectiveness of the Agent paclitaxel-coated balloon catheter compared to balloon angioplasty in patients with in-stent restenosis and high-grade lesions. Interview Questions: 1. What gaps in current treatment approaches for in-stent restenosis did this study aim to address? 2. What was the study design and patient population? 3. What were the key findings? 4. What safety outcomes were measured, and were there any unexpected safety signals? 5. How might these findings influence clinical decision-making for interventional cardiologists treating in-stent restenosis? 6. What further research is required, and what are the next steps? Recorded remotely from New York, 2025. Editors: Yazmin Sadik, Jordan Rance Videographers: Dan Brent, David Ben-Harosh Support: This is an independent interview produced by Radcliffe Cardiology. Visit Radcliffe Cardiology: https://www.radcliffecardiology.com/ This content is intended for healthcare professionals only. Radcliffe brings medical knowledge, insight and innovation to life for CV clinicians around the world, using our communications & creative expertise, our platforms and connections across the community to help transform theory into practice faster. Like us on Facebook:   / radcliffecardiology   Follow us on X: https://x.com/radcliffeCARDIO